US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

4.18

-0.2700-6.07%

Post-market: 4.200.0200+0.48%19:59 EDT

Volume:20.56M

Turnover:86.84M

Market Cap:1.70B

PE:-2.30

High:4.36

Open:4.35

Low:4.11

Close:4.45

Loading ...

Overview Company News Filings

Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Revenue $14.7M, vs. FactSet Est of $15M

MT Newswires Live

Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Net Loss $0.50 a Share, vs. FactSet Est of $0.39 Loss

MT Newswires Live

Recursion Pharmaceuticals Q1 EPS USD -0.5

THOMSON REUTERS

Recursion Pharmaceuticals Q1 EPS $(0.50) Beats $(0.52) Estimate, Sales $14.74M Miss $18.12M Estimate

Recursion Pharmaceuticals Reports Promising Early Results for Familial Adenomatous Polyposis Drug Trial

MT Newswires Live

Recursion Pharmaceuticals Announces Promising Preliminary Results in Phase 1b/2 Trial of REC-4881 for Familial Adenomatous Polyposis

Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden

Medical AI Stocks Soared. HIMS up 7%; Tempus up 6%; RXRX up 4%; Ginkgo up 3%.

Tiger Newspress

Nvidia-Related Stocks Shined. Aurora Jumped 8%; CoreWeave And WeRide Up 7%; Innoviz Up 4%; Nvidia Up 2%

Tiger Newspress

Nvidia-Related and AI-Related Stocks Shined. CoreWeave and Applied Digital up 10%; AppLovin up 6%; Nvidia up 4%

Tiger Newspress

Nvidia-Concept Stocks Shined. CoreWeave Up 8%; Nebius Up 6%; Innoviz Up 5%; Nvidia Up 3%

Tiger Newspress

Recursion Pharmaceuticals (RXRX) Surpasses Market Returns: Some Facts Worth Knowing

Press Release: Recursion to Report First Quarter 2025 Business Updates and Financial Results on May 5th

Recursion Pharmaceuticals to Report Q1 Earnings: What's in the Cards?

Recursion to Present Preliminary Clinical Data from the Ongoing Phase 1b/2 trial of REC-4881 in FAP at Digestive Disease Week 2025

Recursion Pharmaceuticals (RXRX) Stock Moves -1.64%: What You Should Know

Recursion Pharmaceuticals (NasdaqGS:RXRX) Taps Real-World Data With HealthVerity Licensing Deal

Simply Wall St.

BRIEF-Healthverity Partners With Recursion To Enhance Clinical Trial Analytics With Real-World Data

HealthVerity Partners with Recursion to Enhance Clinical Trial Analytics with Real-World Data

Why Recursion Pharmaceuticals, Inc. (RXRX) Went Down On Monday?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RXRX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RXRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RXRX\",,,,,undefined,":{"symbol":"RXRX","market":"US","secType":"STK","nameCN":"Recursion Pharmaceuticals, Inc.","latestPrice":4.18,"timestamp":1748635200000,"preClose":4.45,"halted":0,"volume":20561915,"hourTrading":{"tag":"盘后","latestPrice":4.2,"preClose":4.18,"latestTime":"19:59 EDT","volume":364068,"amount":1524444.054682,"timestamp":1748649591895},"delay":0,"floatShares":388599465,"shares":406916486,"eps":-1.819511,"marketStatus":"Closed","change":-0.27,"latestTime":"05-30 16:00:00 EDT","open":4.35,"high":4.36,"low":4.11,"amount":86835938.2417175,"amplitude":0.05618,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.819511,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1748851200000},"marketStatusCode":5,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":4.45,"preHourTrading":{"tag":"盘前","latestPrice":4.36,"preClose":4.45,"latestTime":"09:29 EDT","volume":251423,"amount":1099658.8320199999,"timestamp":1748611783071},"postHourTrading":{"tag":"盘后","latestPrice":4.2,"preClose":4.18,"latestTime":"19:59 EDT","volume":364068,"amount":1524444.054682,"timestamp":1748649591895},"volumeRatio":1.013357,"impliedVol":0.851,"impliedVolPercentile":0.444},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RXRX\",,,,,undefined,":{"symbol":"RXRX","floatShares":388599465,"roa":"-38.51%","roe":"-86.10%","lyrEps":-1.690915,"volumeRatio":1.013357,"shares":406916486,"dividePrice":0,"high":4.36,"amplitude":0.05618,"preClose":4.45,"low":4.11,"week52Low":3.79,"pbRate":"1.82","psRate":"28.45","week52High":12.36,"institutionHeld":0,"latestPrice":4.18,"eps":-1.819511,"divideRate":0,"volume":20561915,"delay":0,"ttmEps":-1.819511,"open":4.35,"prevYearClose":6.76,"prevWeekClose":4.08,"prevMonthClose":5.59,"prevQuarterClose":5.29,"fiveDayClose":4.145,"twentyDayClose":5.5,"sixtyDayClose":6.58},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RXRX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533302313","title":"Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Revenue $14.7M, vs. FactSet Est of $15M","url":"https://stock-news.laohu8.com/highlight/detail?id=2533302313","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533302313?lang=en_us&edition=fundamental","pubTime":"2025-05-05 18:13","pubTimestamp":1746439997,"startTime":"0","endTime":"0","summary":"Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Revenue $14.7M, vs. FactSet Est of $15M","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"dfa009ab5530609aaf0d1c98097f8736","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RXRX"],"gpt_icon":0},{"id":"2533630231","title":"Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Net Loss $0.50 a Share, vs. FactSet Est of $0.39 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2533630231","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533630231?lang=en_us&edition=fundamental","pubTime":"2025-05-05 18:12","pubTimestamp":1746439950,"startTime":"0","endTime":"0","summary":"Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Net Loss $0.50 a Share, vs. FactSet Est of $0.39 Loss","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"dfa009ab5530609aaf0d1c98097f8736","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RXRX"],"gpt_icon":0},{"id":"2533042003","title":"Recursion Pharmaceuticals Q1 EPS USD -0.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2533042003","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533042003?lang=en_us&edition=fundamental","pubTime":"2025-05-05 18:04","pubTimestamp":1746439446,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nPLX528C70:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RXRX","BK4609","BK4611","BK4139","BK4539","BK4548"],"gpt_icon":0},{"id":"2533830235","title":"Recursion Pharmaceuticals Q1 EPS $(0.50) Beats $(0.52) Estimate, Sales $14.74M Miss $18.12M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533830235","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533830235?lang=en_us&edition=fundamental","pubTime":"2025-05-05 18:01","pubTimestamp":1746439299,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.52) by 3.85 percent. This is a 28.21 percent decrease over losses of $(0.39) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45189433/recursion-pharmaceuticals-q1-eps-0-50-beats-0-52-estimate-sales-14-74m-miss-18-12m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"gpt_icon":1},{"id":"2533303765","title":"Recursion Pharmaceuticals Reports Promising Early Results for Familial Adenomatous Polyposis Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2533303765","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533303765?lang=en_us&edition=fundamental","pubTime":"2025-05-05 16:10","pubTimestamp":1746432624,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals  said Sunday early results from a phase 1/2 trial of its drug REC-4881 for Familial Adenomatous Polyposis showed a median reduction in polyp burden of 43% after 13 weeks among six patients who were evaluated.The company said five patients saw polyp reductions between 31% and 82%, while one experienced a sharp increase compared to  20% to 30% reductions in other drugs over six months.Three patients also showed improvement in the Spigelman stage, while one worsened and two had mixed or unclear results.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4548","BK4611","BK4539","BK4609","RXRX"],"gpt_icon":1},{"id":"2533324588","title":"Recursion Pharmaceuticals Announces Promising Preliminary Results in Phase 1b/2 Trial of REC-4881 for Familial Adenomatous Polyposis","url":"https://stock-news.laohu8.com/highlight/detail?id=2533324588","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533324588?lang=en_us&edition=fundamental","pubTime":"2025-05-05 00:45","pubTimestamp":1746377116,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals Announces Promising Preliminary Results in Phase 1b/2 Trial of REC-4881 for Familial Adenomatous Polyposis. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on May 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250504:nNDL4zwyhb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4139","IE00B64PRP62.GBP","LU2210149790.SGD","BK4548","BK4588","BK4611","BK4112","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4585","BK4539","BK4609","RXRX","NDAQ"],"gpt_icon":1},{"id":"2533334128","title":"Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden","url":"https://stock-news.laohu8.com/highlight/detail?id=2533334128","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533334128?lang=en_us&edition=fundamental","pubTime":"2025-05-05 00:45","pubTimestamp":1746377100,"startTime":"0","endTime":"0","summary":"In the Phase 2 open-label study, REC-4881  led to a median 43% reduction  in polyp burden at the Week 13 assessment at time of data cutoff.Five of six patients (83%) experienced reductions in polyp burden ranging from 31% to 82%, however, one patient showed a substantial increase from baseline.The early safety profile of REC-4881 was generally consistent with that of prior MEK1/2 inhibitors; among 19 patients across Phase 1b and 2, most treatment-related adverse events were Grade 1 or 2, with Grade 3 events in 16% of patients and no Grade ≥4 TRAEs reported to date.Across the combined Phase 1b and ongoing Phase 2 cohorts , REC-4881 demonstrated an early safety profile generally consistent with that of prior MEK1/2 inhibitors. Seventy-nine percent  of patients experienced at least one treatment-related adverse event , the majority of which were Grade 1 or 2 in severity. Grade 3 TRAEs occurred in 16% of patients, with no Grade ≥4 events reported to date. In Phase 1b, the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/preliminary-phase-1b-2-data-164500686.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4609","BK4548","BK4611","BK4181","BK4139","CPK","RXRX","TRAE","PK","BK4197","BK4539","BK4218","REC"],"gpt_icon":1},{"id":"1163309579","title":"Medical AI Stocks Soared. HIMS up 7%; Tempus up 6%; RXRX up 4%; Ginkgo up 3%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1163309579","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163309579?lang=en_us&edition=fundamental","pubTime":"2025-05-02 21:57","pubTimestamp":1746194225,"startTime":"0","endTime":"0","summary":"Medical AI Stocks Soared. HIMS up 7%; Tempus up 6%; RXRX up 4%; Ginkgo up 3%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM","TXG","CRSP","RBOT","RXRX","ABSI","BEAM","DNA"],"gpt_icon":0},{"id":"1126823213","title":"Nvidia-Related Stocks Shined. Aurora Jumped 8%; CoreWeave And WeRide Up 7%; Innoviz Up 4%; Nvidia Up 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126823213","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126823213?lang=en_us&edition=fundamental","pubTime":"2025-05-02 21:44","pubTimestamp":1746193484,"startTime":"0","endTime":"0","summary":"Nvidia-Related Stocks Shined. Aurora jumped 8%; CoreWeave and WeRide up 7%; Innoviz up 4%; Nvidia up 2%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","TM","CRNC","NVDA","ARBE","MU","NBIS","AUR","INVZ","SERV","SOUN","NNOX","APLD","ARM"],"gpt_icon":0},{"id":"1182359128","title":"Nvidia-Related and AI-Related Stocks Shined. CoreWeave and Applied Digital up 10%; AppLovin up 6%; Nvidia up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1182359128","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182359128?lang=en_us&edition=fundamental","pubTime":"2025-05-01 22:29","pubTimestamp":1746109787,"startTime":"0","endTime":"0","summary":"Nvidia-Related Stocks and AI-Related Stocks Shined. CoreWeave and Applied Digital up 10%; Nebius up 8%; AppLovin up 6%; Nvidia and Innoviz up 4%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARM","SERV","APLD","HUBS","ISRG","RXRX","INVZ","NNOX","BIDU","TEM","AUR","BRZE","TM","UPST","NBIS","PLTR","AI","MU","CRNC","ARBE","APP","RBRK","NVDA","SOUN"],"gpt_icon":0},{"id":"1132809281","title":"Nvidia-Concept Stocks Shined. CoreWeave Up 8%; Nebius Up 6%; Innoviz Up 5%; Nvidia Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132809281","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132809281?lang=en_us&edition=fundamental","pubTime":"2025-05-01 16:43","pubTimestamp":1746089013,"startTime":"0","endTime":"0","summary":"Nvidia-concept stocks shined. CoreWeave up 8%; Nebius up 6%; Innoviz up 5%; Nvidia up 3%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AUR","RXRX","INVZ","MU","CRWV","TM","NBIS","NNOX","SERV","SOUN","NVDA","ARM","CRNC","ARBE","APLD"],"gpt_icon":0},{"id":"2531296670","title":"Recursion Pharmaceuticals (RXRX) Surpasses Market Returns: Some Facts Worth Knowing","url":"https://stock-news.laohu8.com/highlight/detail?id=2531296670","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531296670?lang=en_us&edition=fundamental","pubTime":"2025-04-29 05:50","pubTimestamp":1745877015,"startTime":"0","endTime":"0","summary":"The most recent trading session ended with Recursion Pharmaceuticals  standing at $5.84, reflecting a +1.83% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily gain of 0.06%. Elsewhere, the Dow gained 0.28%, while the tech-heavy Nasdaq lost 0.1%.The biotechnology company's stock has dropped by 1.38% in the past month, exceeding the Medical sector's loss of 6.38% and the S&P 500's loss of 4.29%.Investors will be eagerly watching for the performance of Recursion Pharmaceuticals in its upcoming earnings disclosure. The company is expected to report EPS of -$0.44, down 12.82% from the prior-year quarter. In the meantime, our current consensus estimate forecasts the revenue to be $20.15 million, indicating a 46.12% growth compared to the corresponding quarter of the prior year.It is also important to note the recent changes to analyst estimates for Recursion Pharmaceuticals. These latest adjustments often mirror the shifting dynamics of short-term busines","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recursion-pharmaceuticals-rxrx-surpasses-market-215015830.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4139","BK4609","RXRX","BK4548","BK4611"],"gpt_icon":1},{"id":"2530440159","title":"Press Release: Recursion to Report First Quarter 2025 Business Updates and Financial Results on May 5th","url":"https://stock-news.laohu8.com/highlight/detail?id=2530440159","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530440159?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:27","pubTimestamp":1745843220,"startTime":"0","endTime":"0","summary":"Company to host public earnings call on May 5th at 8:00 am ET / 6:00 am MT / 1:00 pm GMT. Salt Lake City, UT, April 28, 2025  -- Recursion , a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its first quarter 2025 financial results on Monday, May 5, 2025, before the open of the financial markets.Recursion  is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world's largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale -- up to millions of wet lab experiments weekly -- and massive c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["L","BK4588","BK4107","RXRX","BK4609","LU0053666078.USD","BK4539","BK4139","BK4585","BK4548","BK4611"],"gpt_icon":0},{"id":"2530686951","title":"Recursion Pharmaceuticals to Report Q1 Earnings: What's in the Cards?","url":"https://stock-news.laohu8.com/highlight/detail?id=2530686951","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530686951?lang=en_us&edition=fundamental","pubTime":"2025-04-25 23:16","pubTimestamp":1745594160,"startTime":"0","endTime":"0","summary":"The Zacks Consensus Estimate is pegged at a loss of 44 cents per share. The Zacks Consensus Estimate for first-quarter revenues is pinned at $20.15 million.Let's see how things might have shaped up for the upcoming quarterly release.In the absence of a marketed product in the company’s commercial portfolio, Recursion Pharmaceuticals only recognizes collaboration and grant revenues from its partners.RXRX has ongoing collaboration agreements with pharma giants like Roche, Bayer, Merck and Sanofi to develop candidates for several oncology indications with differentiated mechanisms of action. The company also collaborated with NVIDIA Corporation, the worldwide leader in visual computing technologies, to build a next-generation platform for the company to develop novel therapies.Recursion Pharmaceuticals is expected to provide updates regarding the clinical-stage pipeline programs on its first-quarter earnings call. RXRX expects several data readouts throughout 2025.General and administrati","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recursion-pharmaceuticals-report-q1-earnings-151600127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RXRX"],"gpt_icon":1},{"id":"2529493595","title":"Recursion to Present Preliminary Clinical Data from the Ongoing Phase 1b/2 trial of REC-4881 in FAP at Digestive Disease Week 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529493595","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529493595?lang=en_us&edition=fundamental","pubTime":"2025-04-23 08:34","pubTimestamp":1745368440,"startTime":"0","endTime":"0","summary":"Salt Lake City, UT, April 22, 2025  -- Recursion , a leading clinical stage TechBio company decoding biology to radically improve lives, will present preliminary data during the 2025 Digestive Disease Week  meeting from its ongoing Phase 1b/2 clinical trial, TUPELO, which is evaluating the safety and preliminary activity of REC-4881 for the treatment of familial adenomatous polyposis . The data will be presented as a late-breaking oral presentation during the Research Forum session on Hereditary GI cancer syndromes on Sunday, May 4, 2025 in San Diego.“We are pleased that DDW has recognized the importance of our data in addressing the unmet needs of the FAP patient population, where no FDA-approved therapies currently exist,” said Najat Khan, PhD, Chief R&D Officer and Chief Commercial Officer at Recursion. “MEK 1/2 inhibition for the potential treatment of FAP was identified through our AI-powered Recursion OS platform, which analyzed cellular models of APC gene loss to uncover a poten","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recursion-present-preliminary-clinical-data-003400160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TRAE","RXRX","BK4609","BK4539","BK4139","BK4611","BK4548","REC"],"gpt_icon":1},{"id":"2529571383","title":"Recursion Pharmaceuticals (RXRX) Stock Moves -1.64%: What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2529571383","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529571383?lang=en_us&edition=fundamental","pubTime":"2025-04-22 05:50","pubTimestamp":1745272232,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals  closed the latest trading day at $5.41, indicating a -1.64% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 2.36%. At the same time, the Dow lost 2.48%, and the tech-heavy Nasdaq lost 2.55%.Prior to today's trading, shares of the biotechnology company had lost 17.67% over the past month. This has lagged the Medical sector's loss of 9.83% and the S&P 500's loss of 5.6% in that time.Market participants will be closely following the financial results of Recursion Pharmaceuticals in its upcoming release. The company's earnings per share  are projected to be -$0.44, reflecting a 12.82% decrease from the same quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $20.15 million, indicating a 46.12% growth compared to the corresponding quarter of the prior year.Investors should also pay attention to any latest changes in analyst estimates for Recursion Pharmaceutical","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recursion-pharmaceuticals-rxrx-stock-moves-215032641.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4548","BK4611","BK4539","RXRX","BK4139","BK4609"],"gpt_icon":1},{"id":"2528090520","title":"Recursion Pharmaceuticals (NasdaqGS:RXRX) Taps Real-World Data With HealthVerity Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2528090520","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528090520?lang=en_us&edition=fundamental","pubTime":"2025-04-19 01:34","pubTimestamp":1744997654,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals recently announced a licensing agreement to integrate HealthVerity's extensive real-world data into its platforms. In the same week, Recursion reported significant advancements in its drug discovery initiatives and clinical studies, including dosing the first patient in a promising Phase 1 trial. Despite the broader market's flat performance over the past week, Recursion's stock price saw a 22% increase, suggesting that these developments reinforced investor confidence. The company's aim to accelerate drug discovery and clinical trials with enhanced data analytics may have added weight to this upward momentum.You should learn about the 4 possible red flags we've spotted with Recursion Pharmaceuticals .NasdaqGS:RXRX Earnings Per Share Growth as at Apr 2025. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recursion-pharmaceuticals-nasdaqgs-rxrx-taps-173414714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RXRX","BK4139","BK4611","BK4548","BK4539","BK4609"],"gpt_icon":1},{"id":"2527211273","title":"BRIEF-Healthverity Partners With Recursion To Enhance Clinical Trial Analytics With Real-World Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2527211273","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527211273?lang=en_us&edition=fundamental","pubTime":"2025-04-16 20:42","pubTimestamp":1744807337,"startTime":"0","endTime":"0","summary":"BRIEF-Healthverity Partners With Recursion To Enhance Clinical Trial Analytics With Real-World DataApril 16 (Reuters) - Recursion Pharmaceuticals Inc RXRX.O:HEALTHVERITY PARTNERS WITH RECURSION TO ENH","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nTUAB5GPQS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4548","BK4609","BK4539","BK4139","BK4611"],"gpt_icon":0},{"id":"2527241285","title":"HealthVerity Partners with Recursion to Enhance Clinical Trial Analytics with Real-World Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2527241285","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527241285?lang=en_us&edition=fundamental","pubTime":"2025-04-16 20:30","pubTimestamp":1744806600,"startTime":"0","endTime":"0","summary":"PHILADELPHIA, April 16, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data  technology and privacy-compliant data exchange, today announced that Recursion , a leading clinical stage TechBio company decoding biology to radically improve lives, has licensed its real-world data to enhance clinical trial design and analytics.Through this agreement, Recursion will integrate HealthVerity de-identified data for over 340M covered lives within the US into its advanced data science and machine learning platforms, the Recursion OS, allowing for deeper insights into patient populations, enhanced trial design and feasibility assessments, as well as clinical operations workflows. By leveraging these high-quality, linked data assets, Recursion seeks to industrialize clinical development, reduce costs, and accelerate the development of novel therapeutics.The HealthVerity approach to real-world data acquisition and governance ensures compliance with HIPAA and other regulatory frameworks w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/healthverity-partners-recursion-enhance-clinical-123000357.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/healthverity-partners-recursion-enhance-clinical-123000357.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4611","BK4609","RXRX","BK4539","BK4548"],"gpt_icon":1},{"id":"2527943012","title":"Why Recursion Pharmaceuticals, Inc. (RXRX) Went Down On Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527943012","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527943012?lang=en_us&edition=fundamental","pubTime":"2025-04-15 13:07","pubTimestamp":1744693671,"startTime":"0","endTime":"0","summary":"Wall Street’s main indices kicked off the trading week in the green territory, albeit with minimal gains, as investors stayed on the sidelines while continuing to digest President Donald Trump’s temporary tax reprieve on technology companies.The S&P 500 recorded the highest gain, up 0.79 percent, while the Dow Jones came second at 0.78 percent. The tech-heavy Nasdaq was also up by 0.64 percent.Meanwhile, 10 companies, predominantly in the technology sector, bucked a broader market optimism, booking modest declines during the session. In this article, let us explore Monday’s 10 worst performers and the reasons behind their gains.A pharmacist in a hospital pharmacy stands next to a row of various drug containers.According to the FDA, the initiative was designed to replace animal testing with “more effective human-relevant methods” in the development of monoclonal antibody therapies and other drugs.According to the FDA, it will begin to encourage the inclusion of New Approach Methodologie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-recursion-pharmaceuticals-inc-rxrx-050751253.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RXRX","BK4609","BK4539","BK4611","BK4139","BK4548"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RXRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-05","symbol":"RXRX","fiscalQuarterEnding":"2025/03","expectedEps":-0.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746417600000,"reportTimeType":"pre","actualEps":-0.5},{"market":"US","date":"2025-02-28","symbol":"RXRX","fiscalQuarterEnding":"2024/12","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2024-11-06","symbol":"RXRX","fiscalQuarterEnding":"2024/09","expectedEps":-0.33,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2024-08-08","symbol":"RXRX","fiscalQuarterEnding":"2024/06","expectedEps":-0.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.4},{"market":"US","date":"2024-05-09","symbol":"RXRX","fiscalQuarterEnding":"2024/03","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.39}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RXRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RXRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.25,"hold":0.75,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.75,"analysts":8,"updateTime":1744257600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RXRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RXRX","date":"2025-05-29","current":-3.111475,"percent":0.990109,"low":-70.058071,"twenty":-13.518345,"median":-6.813762,"eighty":-5.258715,"high":-2.888468,"avg":-12.598748,"sd":14.14998,"marketCap":1788397955},"quantilePoints":[{"date":"2021-04-16","current":-58.334546,"twenty":-47.846928,"median":-32.115501,"eighty":-32.115501,"marketCap":5075455475},{"date":"2021-04-23","current":-56.879709,"twenty":-59.062279,"median":-56.339795,"eighty":-40.143004,"marketCap":4948875976},{"date":"2021-04-30","current":-63.644298,"twenty":-61.178557,"median":-58.334546,"eighty":-53.630508,"marketCap":5537435766},{"date":"2021-05-07","current":-52.840011,"twenty":-62.561963,"median":-58.94099,"eighty":-53.045807,"marketCap":4597398017},{"date":"2021-05-14","current":-35.902007,"twenty":-61.92552,"median":-56.879709,"eighty":-39.880725,"marketCap":3565033379},{"date":"2021-05-21","current":-42.801023,"twenty":-61.029927,"median":-53.097256,"eighty":-37.2852,"marketCap":4250098811},{"date":"2021-05-28","current":-44.682573,"twenty":-59.856128,"median":-44.682573,"eighty":-38.03443,"marketCap":4436934838},{"date":"2021-06-04","current":-49.869549,"twenty":-59.730364,"median":-48.276164,"eighty":-38.587029,"marketCap":4951996317},{"date":"2021-06-11","current":-52.937662,"twenty":-59.304856,"median":-49.547482,"eighty":-39.105727,"marketCap":5256656866},{"date":"2021-06-18","current":-61.75213,"twenty":-59.517138,"median":-51.191719,"eighty":-40.956765,"marketCap":6131924740},{"date":"2021-06-25","current":-57.24319,"twenty":-59.730364,"median":-52.512135,"eighty":-41.61785,"marketCap":5684191558},{"date":"2021-07-02","current":-62.209804,"twenty":-61.602962,"median":-53.354501,"eighty":-41.973819,"marketCap":6177371341},{"date":"2021-07-09","current":-68.057865,"twenty":-62.024607,"median":-55.799882,"eighty":-42.801023,"marketCap":6758077911},{"date":"2021-07-16","current":-55.971873,"twenty":-62.209804,"median":-56.090529,"eighty":-42.834925,"marketCap":5557950999},{"date":"2021-07-23","current":-59.429856,"twenty":-62.024607,"median":-56.802467,"eighty":-43.179036,"marketCap":5901325319},{"date":"2021-07-30","current":-51.445982,"twenty":-61.870786,"median":-56.251562,"eighty":-43.903132,"marketCap":5108534610},{"date":"2021-08-06","current":-48.157508,"twenty":-61.77689,"median":-55.799882,"eighty":-44.682573,"marketCap":4781992365},{"date":"2021-08-13","current":-30.590777,"twenty":-61.75213,"median":-55.166705,"eighty":-43.903132,"marketCap":3785822761},{"date":"2021-08-20","current":-27.023895,"twenty":-61.00629,"median":-53.354501,"eighty":-41.767018,"marketCap":3344396164},{"date":"2021-08-27","current":-30.645233,"twenty":-61.00629,"median":-53.039367,"eighty":-38.681955,"marketCap":3792562099},{"date":"2021-09-03","current":-36.771557,"twenty":-61.00629,"median":-52.184258,"eighty":-36.771557,"marketCap":4550737552},{"date":"2021-09-10","current":-38.514156,"twenty":-60.62659,"median":-51.598541,"eighty":-36.703487,"marketCap":4766396347},{"date":"2021-09-17","current":-36.499276,"twenty":-60.033919,"median":-51.251047,"eighty":-35.871495,"marketCap":4517040865},{"date":"2021-09-24","current":-33.381658,"twenty":-59.802773,"median":-50.513683,"eighty":-35.431934,"marketCap":4131213801},{"date":"2021-10-01","current":-29.76032,"twenty":-59.593166,"median":-48.750789,"eighty":-33.705672,"marketCap":3683047867},{"date":"2021-10-08","current":-25.431051,"twenty":-59.453372,"median":-48.157508,"eighty":-33.348984,"marketCap":3147270547},{"date":"2021-10-15","current":-25.921157,"twenty":-59.402735,"median":-45.826759,"eighty":-32.115501,"marketCap":3207924583},{"date":"2021-10-22","current":-24.192172,"twenty":-59.219665,"median":-44.394408,"eighty":-30.634342,"marketCap":2993950622},{"date":"2021-10-29","current":-26.070911,"twenty":-59.039986,"median":-43.00698,"eighty":-29.708587,"marketCap":3226457761},{"date":"2021-11-05","current":-26.16621,"twenty":-58.468854,"median":-41.767018,"eighty":-28.720206,"marketCap":3238251601},{"date":"2021-11-12","current":-21.544001,"twenty":-58.039592,"median":-40.025065,"eighty":-27.448654,"marketCap":3173689910},{"date":"2021-11-19","current":-22.725594,"twenty":-57.428405,"median":-38.681955,"eighty":-27.078351,"marketCap":3347752776},{"date":"2021-11-26","current":-21.693134,"twenty":-57.263531,"median":-38.514156,"eighty":-26.781565,"marketCap":3195659010},{"date":"2021-12-03","current":-20.327993,"twenty":-57.141485,"median":-37.351309,"eighty":-26.324132,"marketCap":2994557253},{"date":"2021-12-10","current":-21.773437,"twenty":-56.957298,"median":-36.499276,"eighty":-26.011009,"marketCap":3207488525},{"date":"2021-12-17","current":-20.832751,"twenty":-56.833364,"median":-36.084922,"eighty":-25.365703,"marketCap":3068914205},{"date":"2021-12-23","current":-19.249645,"twenty":-56.66686,"median":-35.724023,"eighty":-25.05258,"marketCap":2835703764},{"date":"2021-12-31","current":-19.651158,"twenty":-56.395645,"median":-35.519064,"eighty":-24.241182,"marketCap":2894851340},{"date":"2022-01-07","current":-18.125411,"twenty":-56.260038,"median":-34.511624,"eighty":-22.725594,"marketCap":2670090553},{"date":"2022-01-14","current":-15.842527,"twenty":-56.11426,"median":-33.585868,"eighty":-22.188715,"marketCap":2333794338},{"date":"2022-01-21","current":-12.905752,"twenty":-55.937475,"median":-33.49057,"eighty":-21.83309,"marketCap":1901172071},{"date":"2022-01-28","current":-12.309219,"twenty":-55.746135,"median":-33.122991,"eighty":-21.693134,"marketCap":1813295673},{"date":"2022-02-04","current":-13.077828,"twenty":-55.476906,"median":-32.115501,"eighty":-21.516469,"marketCap":1926521032},{"date":"2022-02-11","current":-13.754663,"twenty":-55.222643,"median":-31.264672,"eighty":-20.864872,"marketCap":2026226945},{"date":"2022-02-18","current":-11.701215,"twenty":-55.029403,"median":-30.590777,"eighty":-20.348642,"marketCap":1723729344},{"date":"2022-02-25","current":-12.320691,"twenty":-54.853113,"median":-29.950916,"eighty":-20.05267,"marketCap":1814985604},{"date":"2022-03-04","current":-8.775911,"twenty":-53.354501,"median":-29.454003,"eighty":-19.249645,"marketCap":1292797008},{"date":"2022-03-11","current":-7.743451,"twenty":-53.191925,"median":-28.861792,"eighty":-18.756359,"marketCap":1140703242},{"date":"2022-03-18","current":-8.225266,"twenty":-53.141072,"median":-27.983685,"eighty":-18.045109,"marketCap":1211680333},{"date":"2022-03-25","current":-6.190668,"twenty":-52.937662,"median":-27.350632,"eighty":-15.842527,"marketCap":1154429495},{"date":"2022-04-01","current":-7.042342,"twenty":-52.840011,"median":-27.091965,"eighty":-14.075873,"marketCap":1313248937},{"date":"2022-04-08","current":-6.089932,"twenty":-52.184258,"median":-26.87414,"eighty":-13.582587,"marketCap":1135644400},{"date":"2022-04-14","current":-6.831713,"twenty":-52.095384,"median":-26.683544,"eighty":-13.460985,"marketCap":1273971011},{"date":"2022-04-22","current":-5.494675,"twenty":-51.693466,"median":-26.404455,"eighty":-13.160425,"marketCap":1024641564},{"date":"2022-04-29","current":-5.707831,"twenty":-51.476494,"median":-26.16621,"eighty":-12.866748,"marketCap":1064390580},{"date":"2022-05-06","current":-5.578944,"twenty":-51.296815,"median":-25.996034,"eighty":-12.339045,"marketCap":1040355954},{"date":"2022-05-13","current":-4.581642,"twenty":-51.245962,"median":-25.66249,"eighty":-12.100432,"marketCap":970121544},{"date":"2022-05-20","current":-4.394802,"twenty":-51.20189,"median":-25.220033,"eighty":-11.412126,"marketCap":930559850},{"date":"2022-05-27","current":-5.012187,"twenty":-50.64929,"median":-25.009015,"eighty":-8.35375,"marketCap":1061285448},{"date":"2022-06-03","current":-5.808288,"twenty":-50.127203,"median":-24.859261,"eighty":-8.087604,"marketCap":1229852666},{"date":"2022-06-10","current":-5.264015,"twenty":-49.483068,"median":-23.980849,"eighty":-7.571374,"marketCap":1114607731},{"date":"2022-06-17","current":-6.190091,"twenty":-48.655864,"median":-22.725594,"eighty":-7.07403,"marketCap":1310696128},{"date":"2022-06-24","current":-7.303008,"twenty":-48.235482,"median":-22.656764,"eighty":-7.052052,"marketCap":1546346220},{"date":"2022-07-01","current":-6.848093,"twenty":-48.167679,"median":-22.203629,"eighty":-6.817171,"marketCap":1450022095},{"date":"2022-07-08","current":-7.278638,"twenty":-48.052412,"median":-21.997137,"eighty":-6.834989,"marketCap":1541185999},{"date":"2022-07-15","current":-6.904958,"twenty":-47.499813,"median":-21.773437,"eighty":-6.702198,"marketCap":1462062611},{"date":"2022-07-22","current":-6.360684,"twenty":-46.513271,"median":-21.693134,"eighty":-6.662878,"marketCap":1346817675},{"date":"2022-07-29","current":-6.872464,"twenty":-44.662232,"median":-21.566945,"eighty":-6.62551,"marketCap":1455182316},{"date":"2022-08-05","current":-8.050368,"twenty":-44.543576,"median":-21.435019,"eighty":-6.646631,"marketCap":1704592997},{"date":"2022-08-12","current":-8.909121,"twenty":-44.296153,"median":-20.993356,"eighty":-6.646631,"marketCap":2083843359},{"date":"2022-08-19","current":-7.25161,"twenty":-43.758313,"median":-20.677882,"eighty":-6.662878,"marketCap":1696151571},{"date":"2022-08-26","current":-7.80658,"twenty":-43.110214,"median":-20.327993,"eighty":-6.702198,"marketCap":1825959090},{"date":"2022-09-02","current":-7.569793,"twenty":-42.828145,"median":-20.05267,"eighty":-6.706427,"marketCap":1770574548},{"date":"2022-09-09","current":-9.819272,"twenty":-42.801023,"median":-19.530704,"eighty":-6.718117,"marketCap":2296727689},{"date":"2022-09-16","current":-7.99157,"twenty":-41.767018,"median":-19.249645,"eighty":-6.742488,"marketCap":1869228262},{"date":"2022-09-23","current":-7.984171,"twenty":-41.580558,"median":-19.014474,"eighty":-6.807476,"marketCap":1867497495},{"date":"2022-09-30","current":-7.873177,"twenty":-40.800817,"median":-18.653113,"eighty":-6.831713,"marketCap":1841535992},{"date":"2022-10-07","current":-7.976771,"twenty":-39.249314,"median":-18.08526,"eighty":-6.848093,"marketCap":1865766728},{"date":"2022-10-14","current":-7.762183,"twenty":-38.97012,"median":-17.001177,"eighty":-6.872464,"marketCap":1815574488},{"date":"2022-10-21","current":-8.228357,"twenty":-38.681955,"median":-15.068182,"eighty":-6.896834,"marketCap":1924612803},{"date":"2022-10-28","current":-8.206159,"twenty":-38.563298,"median":-14.156175,"eighty":-6.904958,"marketCap":1919420503},{"date":"2022-11-04","current":-7.133216,"twenty":-38.514156,"median":-13.89806,"eighty":-6.953698,"marketCap":1668459301},{"date":"2022-11-11","current":-9.580773,"twenty":-38.378015,"median":-13.582587,"eighty":-6.955626,"marketCap":2365655697},{"date":"2022-11-18","current":-7.538717,"twenty":-37.681851,"median":-13.50802,"eighty":-7.042342,"marketCap":1861437415},{"date":"2022-11-25","current":-7.108811,"twenty":-37.152983,"median":-13.335943,"eighty":-7.027999,"marketCap":1755286198},{"date":"2022-12-02","current":-7.147195,"twenty":-36.821399,"median":-13.181074,"eighty":-6.967626,"marketCap":1764763985},{"date":"2022-12-09","current":-6.617489,"twenty":-36.553732,"median":-12.99179,"eighty":-6.967626,"marketCap":1633970521},{"date":"2022-12-16","current":-6.471628,"twenty":-36.444819,"median":-12.710731,"eighty":-6.903333,"marketCap":1597954930},{"date":"2022-12-23","current":-5.765353,"twenty":-36.300511,"median":-12.372314,"eighty":-6.827253,"marketCap":1423563644},{"date":"2022-12-30","current":-5.918891,"twenty":-36.048339,"median":-12.320691,"eighty":-6.794058,"marketCap":1461474793},{"date":"2023-01-06","current":-5.711615,"twenty":-35.840984,"median":-12.25186,"eighty":-6.709349,"marketCap":1410294742},{"date":"2023-01-13","current":-6.678904,"twenty":-35.729108,"median":-11.701215,"eighty":-6.66344,"marketCap":1649134981},{"date":"2023-01-20","current":-6.64052,"twenty":-35.66269,"median":-11.483251,"eighty":-6.646631,"marketCap":1639657194},{"date":"2023-01-27","current":-6.556074,"twenty":-35.519064,"median":-10.015362,"eighty":-6.618118,"marketCap":1618806062},{"date":"2023-02-03","current":-7.400533,"twenty":-35.431934,"median":-9.819272,"eighty":-6.606014,"marketCap":1827317381},{"date":"2023-02-10","current":-6.287382,"twenty":-35.004453,"median":-9.645381,"eighty":-6.59378,"marketCap":1552461551},{"date":"2023-02-17","current":-6.133844,"twenty":-34.617814,"median":-9.493689,"eighty":-6.556255,"marketCap":1514550402},{"date":"2023-02-24","current":-5.842122,"twenty":-34.334641,"median":-9.104805,"eighty":-6.520348,"marketCap":1442519219},{"date":"2023-03-03","current":-6.771673,"twenty":-33.735623,"median":-8.837897,"eighty":-6.508153,"marketCap":1621653202},{"date":"2023-03-10","current":-5.645723,"twenty":-33.585868,"median":-8.761129,"eighty":-6.502335,"marketCap":1352015111},{"date":"2023-03-17","current":-5.917229,"twenty":-33.55864,"median":-8.632225,"eighty":-6.468226,"marketCap":1417034225},{"date":"2023-03-24","current":-5.342275,"twenty":-33.49057,"median":-8.529037,"eighty":-6.394859,"marketCap":1279346689},{"date":"2023-03-31","current":-5.326304,"twenty":-33.381658,"median":-8.384524,"eighty":-6.370676,"marketCap":1275522035},{"date":"2023-04-06","current":-5.150624,"twenty":-33.250963,"median":-8.261655,"eighty":-6.344393,"marketCap":1233450844},{"date":"2023-04-14","current":-5.230479,"twenty":-33.065811,"median":-8.206159,"eighty":-6.298729,"marketCap":1252574112},{"date":"2023-04-21","current":-4.344092,"twenty":-32.774471,"median":-8.167907,"eighty":-6.267962,"marketCap":1040305828},{"date":"2023-04-28","current":-3.904892,"twenty":-32.311563,"median":-8.118028,"eighty":-6.189087,"marketCap":935127849},{"date":"2023-05-05","current":-4.127735,"twenty":-32.115501,"median":-8.080365,"eighty":-6.130932,"marketCap":988493466},{"date":"2023-05-12","current":-4.173613,"twenty":-31.641762,"median":-8.069266,"eighty":-6.103512,"marketCap":1038495081},{"date":"2023-05-19","current":-4.228715,"twenty":-31.25242,"median":-8.058167,"eighty":-6.088073,"marketCap":1052205808},{"date":"2023-05-26","current":-6.694821,"twenty":-30.868503,"median":-8.050567,"eighty":-6.088073,"marketCap":1665832230},{"date":"2023-06-02","current":-6.77986,"twenty":-30.623451,"median":-8.039668,"eighty":-6.089932,"marketCap":1686991762},{"date":"2023-06-09","current":-7.065897,"twenty":-30.405626,"median":-8.018774,"eighty":-6.091123,"marketCap":1758164733},{"date":"2023-06-16","current":-7.189589,"twenty":-30.057106,"median":-7.980471,"eighty":-6.093929,"marketCap":1788942234},{"date":"2023-06-23","current":-5.960401,"twenty":-29.912797,"median":-7.958272,"eighty":-6.093419,"marketCap":1483090819},{"date":"2023-06-30","current":-5.705287,"twenty":-29.76032,"median":-7.941617,"eighty":-6.085284,"marketCap":1419612224},{"date":"2023-07-07","current":-5.094558,"twenty":-29.553386,"median":-7.928674,"eighty":-6.021762,"marketCap":1267648314},{"date":"2023-07-14","current":-9.998302,"twenty":-29.425414,"median":-7.924974,"eighty":-6.000489,"marketCap":2487817514},{"date":"2023-07-21","current":-11.907909,"twenty":-29.123182,"median":-7.941617,"eighty":-6.003337,"marketCap":2962973653},{"date":"2023-07-28","current":-10.380224,"twenty":-28.899911,"median":-7.969371,"eighty":-6.021762,"marketCap":2582848742},{"date":"2023-08-04","current":-9.950059,"twenty":-28.295447,"median":-7.98787,"eighty":-6.059865,"marketCap":2475813569},{"date":"2023-08-11","current":-8.275591,"twenty":-28.077623,"median":-8.035968,"eighty":-6.077733,"marketCap":2151570954},{"date":"2023-08-18","current":-7.28053,"twenty":-27.938759,"median":-7.98787,"eighty":-6.084248,"marketCap":1892865028},{"date":"2023-08-25","current":-7.106394,"twenty":-27.560289,"median":-7.969371,"eighty":-6.089002,"marketCap":1847591491},{"date":"2023-09-01","current":-7.214193,"twenty":-27.375137,"median":-7.941617,"eighty":-6.089932,"marketCap":1875617966},{"date":"2023-09-08","current":-6.932259,"twenty":-27.277116,"median":-7.933993,"eighty":-6.091718,"marketCap":1802317953},{"date":"2023-09-15","current":-7.131271,"twenty":-27.146421,"median":-7.873177,"eighty":-6.09444,"marketCap":1854059139},{"date":"2023-09-22","current":-6.608864,"twenty":-27.091965,"median":-7.821379,"eighty":-6.103512,"marketCap":1718238527},{"date":"2023-09-29","current":-6.44302,"twenty":-27.051123,"median":-7.80658,"eighty":-6.118463,"marketCap":1675120873},{"date":"2023-10-06","current":-5.895737,"twenty":-26.934042,"median":-7.777522,"eighty":-6.09444,"marketCap":1532832613},{"date":"2023-10-13","current":-5.248947,"twenty":-26.857803,"median":-7.762183,"eighty":-6.083213,"marketCap":1364673761},{"date":"2023-10-20","current":-5.016766,"twenty":-26.748891,"median":-7.715647,"eighty":-6.003337,"marketCap":1304309045},{"date":"2023-10-27","current":-4.602157,"twenty":-26.683544,"median":-7.693671,"eighty":-5.989098,"marketCap":1196514909},{"date":"2023-11-03","current":-4.336808,"twenty":-26.574631,"median":-7.665988,"eighty":-5.973127,"marketCap":1127526662},{"date":"2023-11-10","current":-3.872477,"twenty":-26.452105,"median":-7.62151,"eighty":-5.937198,"marketCap":1132939550},{"date":"2023-11-17","current":-4.938704,"twenty":-26.356806,"median":-7.594318,"eighty":-5.918891,"marketCap":1444877017},{"date":"2023-11-24","current":-5.079386,"twenty":-26.291459,"median":-7.562464,"eighty":-5.894282,"marketCap":1486035433},{"date":"2023-12-01","current":-5.071982,"twenty":-26.187992,"median":-7.537838,"eighty":-5.86155,"marketCap":1483869200},{"date":"2023-12-08","current":-5.582882,"twenty":-26.089971,"median":-7.522342,"eighty":-5.835247,"marketCap":1633339237},{"date":"2023-12-15","current":-7.056349,"twenty":-26.070911,"median":-7.429201,"eighty":-5.826916,"marketCap":2064419486},{"date":"2023-12-22","current":-7.285884,"twenty":-25.951108,"median":-7.414401,"eighty":-5.829021,"marketCap":2131572691},{"date":"2023-12-29","current":-7.856019,"twenty":-25.915711,"median":-7.427886,"eighty":-5.832323,"marketCap":2298372587},{"date":"2024-01-05","current":-8.226237,"twenty":-25.907543,"median":-7.421801,"eighty":-5.836709,"marketCap":2406684207},{"date":"2024-01-12","current":-8.329897,"twenty":-25.66249,"median":-7.47051,"eighty":-5.842122,"marketCap":2437011461},{"date":"2024-01-19","current":-7.322905,"twenty":-25.477339,"median":-7.513381,"eighty":-5.842122,"marketCap":2142403853},{"date":"2024-01-26","current":-7.574653,"twenty":-25.300356,"median":-7.529295,"eighty":-5.854405,"marketCap":2216055755},{"date":"2024-02-02","current":-7.071157,"twenty":-25.191444,"median":-7.513381,"eighty":-5.86155,"marketCap":2068751951},{"date":"2024-02-09","current":-7.33031,"twenty":-25.128819,"median":-7.433971,"eighty":-5.864636,"marketCap":2144570085},{"date":"2024-02-16","current":-9.203611,"twenty":-25.030798,"median":-7.453796,"eighty":-5.883577,"marketCap":2692626885},{"date":"2024-02-23","current":-11.10653,"twenty":-25.000847,"median":-7.513381,"eighty":-5.888349,"marketCap":3249348615},{"date":"2024-03-01","current":-8.88769,"twenty":-24.913717,"median":-7.536959,"eighty":-5.892826,"marketCap":2915748823},{"date":"2024-03-08","current":-7.990835,"twenty":-24.532523,"median":-7.555029,"eighty":-5.908632,"marketCap":2621521334},{"date":"2024-03-15","current":-7.725668,"twenty":-24.241182,"median":-7.562464,"eighty":-5.918226,"marketCap":2534529146},{"date":"2024-03-22","current":-7.632502,"twenty":-23.938584,"median":-7.584485,"eighty":-5.918891,"marketCap":2503964323},{"date":"2024-03-28","current":-7.288502,"twenty":-23.439139,"median":-7.566128,"eighty":-5.924614,"marketCap":2391109593},{"date":"2024-04-05","current":-6.256501,"twenty":-22.856372,"median":-7.547594,"eighty":-5.933617,"marketCap":2052545403},{"date":"2024-04-12","current":-6.392668,"twenty":-22.725594,"median":-7.537838,"eighty":-5.934247,"marketCap":2097217067},{"date":"2024-04-19","current":-5.303335,"twenty":-22.698062,"median":-7.522342,"eighty":-5.918891,"marketCap":1739843755},{"date":"2024-04-26","current":-5.687229,"twenty":-22.509925,"median":-7.487706,"eighty":-5.888294,"marketCap":1865786343},{"date":"2024-05-03","current":-6.37637,"twenty":-22.285078,"median":-7.433971,"eighty":-5.888294,"marketCap":2091870148},{"date":"2024-05-10","current":-6.267558,"twenty":-22.218542,"median":-7.418101,"eighty":-5.889214,"marketCap":2056172705},{"date":"2024-05-17","current":-6.382694,"twenty":-22.10153,"median":-7.396002,"eighty":-5.889214,"marketCap":2260188615},{"date":"2024-05-24","current":-6.060539,"twenty":-22.009755,"median":-7.373614,"eighty":-5.892501,"marketCap":2146109694},{"date":"2024-05-31","current":-5.953154,"twenty":-21.908804,"median":-7.332906,"eighty":-5.891423,"marketCap":2108083387},{"date":"2024-06-07","current":-6.047116,"twenty":-21.800969,"median":-7.322905,"eighty":-5.888238,"marketCap":2141356406},{"date":"2024-06-14","current":-6.335713,"twenty":-21.773437,"median":-7.303407,"eighty":-5.865153,"marketCap":2243552105},{"date":"2024-06-21","current":-6.141078,"twenty":-21.773437,"median":-7.303008,"eighty":-5.883577,"marketCap":2174629424},{"date":"2024-06-28","current":-5.738877,"twenty":-21.757376,"median":-7.303008,"eighty":-5.869759,"marketCap":2032205183},{"date":"2024-07-05","current":-5.566859,"twenty":-21.693134,"median":-7.288502,"eighty":-5.842122,"marketCap":1971291403},{"date":"2024-07-12","current":-5.816799,"twenty":-21.693134,"median":-7.283207,"eighty":-5.827511,"marketCap":2059798364},{"date":"2024-07-15","current":-6.331828,"twenty":-21.677074,"median":-7.28053,"eighty":-5.827889,"marketCap":2242176344},{"date":"2024-08-02","current":-5.559285,"twenty":-21.661013,"median":-7.279584,"eighty":-5.825725,"marketCap":1968609374},{"date":"2024-08-09","current":-4.749917,"twenty":-21.594477,"median":-7.25161,"eighty":-5.796615,"marketCap":1780867335},{"date":"2024-08-16","current":-5.013463,"twenty":-21.557767,"median":-7.227678,"eighty":-5.772377,"marketCap":1879677766},{"date":"2024-08-23","current":-5.508065,"twenty":-21.530235,"median":-7.214193,"eighty":-5.759019,"marketCap":2065116828},{"date":"2024-08-30","current":-5.553029,"twenty":-21.449933,"median":-7.191423,"eighty":-5.72252,"marketCap":2081974925},{"date":"2024-09-06","current":-4.623777,"twenty":-21.328332,"median":-7.189279,"eighty":-5.708345,"marketCap":1733574262},{"date":"2024-09-13","current":-4.871078,"twenty":-21.15855,"median":-7.174818,"eighty":-5.703384,"marketCap":1826293794},{"date":"2024-09-20","current":-5.200813,"twenty":-20.961235,"median":-7.166206,"eighty":-5.674587,"marketCap":1949919835},{"date":"2024-09-27","current":-5.373174,"twenty":-20.802924,"median":-7.150935,"eighty":-5.651287,"marketCap":2014542538},{"date":"2024-10-04","current":-4.541343,"twenty":-20.681324,"median":-7.144123,"eighty":-5.637453,"marketCap":1702667752},{"date":"2024-10-11","current":-4.631271,"twenty":-20.623965,"median":-7.139563,"eighty":-5.608986,"marketCap":1736383945},{"date":"2024-10-18","current":-4.908548,"twenty":-20.41059,"median":-7.132243,"eighty":-5.58344,"marketCap":1840342207},{"date":"2024-10-25","current":-4.766162,"twenty":-20.323404,"median":-7.130392,"eighty":-5.573856,"marketCap":1786958235},{"date":"2024-10-31","current":-5.005969,"twenty":-20.305049,"median":-7.114687,"eighty":-5.559285,"marketCap":1876868083},{"date":"2024-11-08","current":-5.262167,"twenty":-20.05267,"median":-7.106394,"eighty":-5.527369,"marketCap":1987788975},{"date":"2024-11-15","current":-5.246981,"twenty":-20.05267,"median":-7.093457,"eighty":-5.523053,"marketCap":1982052210},{"date":"2024-11-22","current":-4.366156,"twenty":-19.651158,"median":-7.076099,"eighty":-5.496661,"marketCap":1649319857},{"date":"2024-11-29","current":-5.368474,"twenty":-19.458432,"median":-7.072192,"eighty":-5.484495,"marketCap":2027946328},{"date":"2024-12-06","current":-5.003995,"twenty":-19.382718,"median":-7.065897,"eighty":-5.453819,"marketCap":1890263975},{"date":"2024-12-13","current":-5.300134,"twenty":-19.274883,"median":-7.044868,"eighty":-5.453819,"marketCap":2002130887},{"date":"2024-12-20","current":-4.624329,"twenty":-19.212935,"median":-7.011782,"eighty":-5.426221,"marketCap":1746844857},{"date":"2024-12-27","current":-5.816479,"twenty":-19.14181,"median":-7.004518,"eighty":-5.425958,"marketCap":2197180887},{"date":"2025-01-03","current":-5.47478,"twenty":-19.031682,"median":-6.997114,"eighty":-5.418488,"marketCap":2068103681},{"date":"2025-01-10","current":-5.512747,"twenty":-18.894021,"median":-6.98598,"eighty":-5.425431,"marketCap":2082445593},{"date":"2025-01-17","current":-4.859722,"twenty":-18.73571,"median":-6.969061,"eighty":-5.406215,"marketCap":1835764710},{"date":"2025-01-24","current":-7.862234,"twenty":-18.653113,"median":-6.978303,"eighty":-5.40644,"marketCap":2969966606},{"date":"2025-01-31","current":-8.029293,"twenty":-18.515452,"median":-6.993657,"eighty":-5.406498,"marketCap":3033073466},{"date":"2025-02-07","current":-7.559438,"twenty":-18.125411,"median":-7.001557,"eighty":-5.414034,"marketCap":2855585422},{"date":"2025-02-14","current":-8.875031,"twenty":-18.045109,"median":-7.011782,"eighty":-5.425168,"marketCap":3352551946},{"date":"2025-02-21","current":-10.806656,"twenty":-17.778963,"median":-7.042342,"eighty":-5.426221,"marketCap":4082225016},{"date":"2025-02-28","current":-8.008411,"twenty":-17.143427,"median":-7.061123,"eighty":-5.430397,"marketCap":3025185108},{"date":"2025-03-07","current":-5.414026,"twenty":-16.156854,"median":-7.042342,"eighty":-5.430397,"marketCap":2510272533},{"date":"2025-03-14","current":-5.153736,"twenty":-15.863176,"median":-7.010397,"eighty":-5.414032,"marketCap":2389586354},{"date":"2025-03-21","current":-5.622257,"twenty":-14.603575,"median":-6.998596,"eighty":-5.422941,"marketCap":2606821477},{"date":"2025-03-28","current":-5.179765,"twenty":-14.202063,"median":-6.989819,"eighty":-5.414032,"marketCap":2401654972},{"date":"2025-04-04","current":-4.173311,"twenty":-14.160764,"median":-6.970626,"eighty":-5.403178,"marketCap":1935001744},{"date":"2025-04-11","current":-3.913022,"twenty":-14.091933,"median":-6.954662,"eighty":-5.372463,"marketCap":1814315565},{"date":"2025-04-17","current":-4.615804,"twenty":-14.055224,"median":-6.937232,"eighty":-5.367577,"marketCap":2140168249},{"date":"2025-04-25","current":-4.988886,"twenty":-13.869381,"median":-6.907382,"eighty":-5.353417,"marketCap":2313151773},{"date":"2025-05-02","current":-4.771978,"twenty":-13.692715,"median":-6.900193,"eighty":-5.326304,"marketCap":2212579957},{"date":"2025-05-09","current":-3.107935,"twenty":-13.610119,"median":-6.878644,"eighty":-5.313929,"marketCap":1786363373},{"date":"2025-05-16","current":-3.008821,"twenty":-13.548172,"median":-6.855621,"eighty":-5.296244,"marketCap":1729395065},{"date":"2025-05-23","current":-2.934485,"twenty":-13.525228,"median":-6.818513,"eighty":-5.266107,"marketCap":1686668834},{"date":"2025-05-29","current":-3.111475,"twenty":-13.518345,"median":-6.813762,"eighty":-5.258715,"marketCap":1788397955}],"updateTime":1748658309959}}}